Frazier Life Sciences Public Fund, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Savara Inc. Common Stock, par value $0.001 per share (SVRA)

Filing Manager
Frazier Life Sciences Public Fund, L.P.
Reporting Manager
Frazier Life Sciences Public Fund, L.P.
Security
Savara Inc. Common Stock, par value $0.001 per share
Symbol
SVRA
Shares outstanding
203,488,976 shares
Disclosed Ownership
8,343,048 shares
Ownership
4.1%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 17:30:14 UTC
Date of event
31 Dec 2025
Previous filing
14 Aug 2025
SEC
View on sec.gov

Quoteable Key Fact

"Frazier Life Sciences Public Fund, L.P. disclosed 4.1% ownership in Savara Inc. Common Stock, par value $0.001 per share (SVRA) on 31 Dec 2025."

Quick Takeaways

  • Frazier Life Sciences Public Fund, L.P. filed SCHEDULE 13G/A for Savara Inc. Common Stock, par value $0.001 per share (SVRA).
  • Disclosed ownership: 4.1%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 14 Aug 2025.
  • Current filing was accepted on 13 Feb 2026, 17:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (11)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Frazier Life Sciences Public Fund, L.P. 4.1% 8,343,048 0 8,343,048 /s/ Jennifer Martin By Jennifer Martin, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P.
FHMLSP, L.P. 4.1% 8,343,048 0 8,343,048 /s/ Jennifer Martin By Jennifer Martin, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P.
FHMLSP, L.L.C. 4.1% 8,343,048 0 8,343,048 /s/ Jennifer Martin By Jennifer Martin, CFO of FHMLSP, L.L.C.
Frazier Life Sciences X, L.P. 0.1% 279,365 0 279,365 /s/ Jennifer Martin By Jennifer Martin, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P.
FHMLS X, L.P. 0.1% 279,365 0 279,365 /s/ Jennifer Martin By Jennifer Martin, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P.
FHMLS X, L.L.C. 0.1% 279,365 0 279,365 /s/ Jennifer Martin By Jennifer Martin, CFO of FHMLS X, L.L.C.
Frazier Life Sciences XI, L.P. 0.6% 1,239,888 0 1,239,888 /s/ Jennifer Martin By Jennifer Martin, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P.
FHMLS XI, L.P. 0.6% 1,239,888 0 1,239,888 /s/ Jennifer Martin By Jennifer Martin, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P.
FHMLS XI, L.L.C. 0.6% 1,239,888 0 1,239,888 /s/ Jennifer Martin By Jennifer Martin, CFO of FHMLS XI, L.L.C.
James N. Topper 0.1% 279,365 0 279,365 /s/ Jennifer Martin By Jennifer Martin, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on January 27, 2026
Patrick J. Heron 0.1% 279,365 0 279,365 /s/ Jennifer Martin By Jennifer Martin, Attorney-in-Fact for Patrick Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on January 27, 2026